"We're really pushing hard to get into that second position behind orforglipron, now Foundayo." Pfizer also unveiled mid-stage data from a shot it gained through its $10 billion acquisition of Metsera
Insurance coverage for GLP-1-linked nutrition began in Q4 2025
Our retatrutide sourcing safety guide covers why purchasing the medication on the grey market isnt worth the risk
FDA Commissioner Marty Makary, M.D., publicly pledged to take swift action against companies that mass-market what he characterized as illegal copycat drugs. While Hims & Hers ultimately retreated from its plans in the face of mounting legal pressure, the episode served as a watershed moment, putting the industry on notice that the FDA intended to draw a firm line between legitimate compounding and unauthorized mass-market drug distribution
The 21 NAION plaintiffs have asked a New Jersey state court to consolidate their cases into a multicounty litigation (MCL) docket
After applying the savings offer, collect the remaining out-of-pocket cost from the patient as shown on the adjudicated claim
